All News

International company PQE Group announced in late October their first ever start-up to provide support for medical cannabis.

For the first time, the Association of Official Analytical Collaboration (AOAC) INTERNATIONAL Research Institute granted its Reviewed and Recognized certification to a cannabis potency testing laboratory.

Earlier this month, Committee D37 on Cannabis, a committee within ASTM International, released descriptions of their four new standards for cannabis testing and who they will benefit within the industry.

In a recent announcement, Major League Baseball announced a sponsorship deal with cannabidiol (CBD) company Charlotte’s Web.

The 2022 Canna Pharma Conference was held October 12-13 in San Diego, California.

In a statement released from the White House on October 6, 2022, President Joe Biden announced plans to pardon Federal convictions for simple possession of marijuana and issued a call to review the scheduling of cannabis (1).

The Association of Official Analytical Collaboration (AOAC) INTERNATIONAL announced the winners of more than a dozen awards presented at their Annual Meeting.

Recently, some major food and beverage companies expressed interest in selling products containing cannabidiol (CBD), but the Food and Drug Administration (FDA) have not indicated any regulatory progress.

Cannabis Science Conference East was held in Baltimore, Maryland from September 14-16, 2022. Here we provide a few highlights from the event.

In a presentation for the psychedelics track at Cannabis Science Conference East 2022, Janie Maedler, Vice President of Rylie’s Smile Foundation and President of Rylie’s Sunshine LLC, led a panel discussion with Rylie Maedler, President of Rylie’s Smile and CEO of Rylie’s Sunshine LLC; Rita Lynn Lawrence, a cannabis patient advocate; and University of Miami cannabis epidemiologist Dr. Denise Vidot. The presentation titled “Psychedelics for Beginners” discussed the basics of using psychedelics for treating mental health issues safely and successfully. Here are some highlights from the session.

In his presentation for the psychedelics track at Cannabis Science Conference East 2022, James Schwartz, BSN, LNC, presented “A New Beginning for an Old Therapy: Case Series Review on the Treatment of PTSD and Other Psychiatric Disorders with Psilocybin and Other Psychedelics.” He reviewed the current research and clinical trials studying the effects of psilocybin, plus side effects, potential uses, latest trends, disorders currently being studied, and potential future applications. Schwartz was a trauma trained nurse who worked in the Trauma/Critical Care ICU at Oregon Health and Science University. He is an experienced medical legal consultant and CEO of Cascade High. Here are some highlights from his session.

In his keynote address for the psychedelics track at Cannabis Science Conference East 2022, Dr. Matthew Johnson presented his talk “Psilocybin in the Treatment of Tobacco Addiction,” which reviewed the treatment of substance use disorders with classic psychedelics (5HT2A agonists) including LSD and psilocybin. Dr. Matthew Johnson, PhD, is the Susan Hill Ward Professor of Psychedelics at Johns Hopkins and is one of the world’s most widely published experts on psychedelics. Here are some highlights from his session.

In a keynote address for the psychedelics track at Cannabis Science Conference East 2022, Dr. Andrew Coop, Dr. Chad Johnson, and Dr. Leah Sera of the University of Maryland School of Pharmacy presented “There’S Room for Everyone: The Emerging Field of Psychedelic Therapeutics.” The talk focused on the history of psychedelics, “classical” and “nonclassical” psychedelics, the current clinical research studies on psychedelics, and the announcement of a master’s program in the Cannabis Science and Therapeutics program at the University of Maryland School of Pharmacy. Here are some highlights from the session.

Dr. Anthony Macherone of Agilent Technologies shares some insights from his talk at Cannabis Science Conference East 2022.

A recent study disclosed how younger generations are experimenting with cannabis and hallucinogenic use at the highest levels according to data from previous years.

View our amazing agenda in the Final Program & Exhibitor Guide for Cannabis Science Conference East 2022!

Recently in France, 31 senators published a co-signed letter in the French newspaper “Le Monde,” calling for the launch of a consultation process to introduce new laws to legalize cannabis in France.

The National Institute on Drug Abuse (NIDA) recently posted a notice to Drug Enforcement Agency-approved cannabis manufacturers that they will soon be able to submit applications to supply cannabis for research purposes. Currently, NIDA has only worked with one cannabis farm for the past 50 years–the new cannabis supplier selected by NIDA would be the second federally authorized in the country.

Recently, Leafreport, an Israeli company that provides reviews and comparisons of cannabidiol (CBD) companies and products, released their 2022 report on their transparency analysis for 4384 CBD products.

BrandTech Scientific introduces a new logo for its Vacuubrand product line

Cannabis Science Conference West was held in Long Beach, California from May 18–20, 2022. Here we provide a few highlights from the event.

Ellsworth Corporation, a global distributor of specialty chemicals and equipment, recently announced their acquisition of TapeCase Ltd., a distributor of adhesive tape products.

On May 19, 2022 a federal appeals court ruled in a California vaping dispute that delta-8 tetrahydrocannabinol (THC) derived from hemp is “lawful.”

CannMed held their 2022 medical practicum and science conference in Pasadena, California from May 3 – 5.

On June 14–15, Natoli Engineering Company, a manufacturer of tablet compression tooling, is offering hands-on training on how to sharpen skills in tablet press setup, operation, and maintenance procedures.

Medicare Plans, a patient support center that provides resources for better understanding Medicare, recently conducted a survey about the idea of Medicare coverage for medical cannabis treatment and products. Here are some highlights from their results.

The United Kingdom (UK), the first country to formally regulate the market for consumer cannabinoid products, recently released a list of cannabinoid product legally permitted for sale.

In this interview series, we speak to each of the organizers to learn more about them and what attendees can expect from the practicum. Here, Dr. Dustin Sulak and Eloise Theisen share some of the clinical applications for medical cannabis, dosing information, how cannabis can be used to stop opioid addiction, and more.

A new commission for the United Kingdom (UK), the Hodges Review of UK Public Policy and Regulatory Stewardship of the Legal Cannabis Industry, will analyze its current legal cannabis industry and make recommendations on how to best maximize its growth, consumer satisfaction, and competitive potential on a global scale.

The cannabis industry continues to step up and help raise money for humanitarian efforts in support of Ukraine.